| Symbol | AMRN |
|---|---|
| Name | AMARIN CORP PLC\UK |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Pharmaceutical Preparations |
| Address | SPACES SOUTH DOCKLANDS, BLOCK C, DUBLIN 2, None None |
| Telephone | 353 1 6699 020 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | — |
| Description | None |
Bonfiglio Patrice Eadon 🟡 adjusted position in 1.3K shares (1 derivative) of AMARIN CORP PLC\UK (AMRN) at $14.98 Transaction Date: Apr 18, 2026 | Filing ID: 170731
Read moreCohen Paul 🟡 adjusted position in 1.3K shares (1 derivative) of AMARIN CORP PLC\UK (AMRN) at $14.98 Transaction Date: Apr 18, 2026 | Filing ID: 167117
Read moreAmarin to Report First Quarter 2026 Financial Results and Host Conference Call on April 29, 2026
Read moreNew Form ARS - AMARIN CORP PLC\UK <b>Filed:</b> 2026-04-10 <b>AccNo:</b> 0001193125-26-151420 <b>Size:</b> 1 MB
Read moreAmerican College of Cardiology (ACC) Scientific Sessions 2026 Underscore the Need for Complementary Therapies Including Icosapent Ethyl (IPE) in Treatment of Elevated Triglycerides and Cardiovascular Risk Reduction
Read moreFishman Peter L. 🟡 adjusted position in 188 shares (1 derivative) of AMARIN CORP PLC\UK (AMRN) at $14.46 Transaction Date: Apr 01, 2026 | Filing ID: 140264
Read moreNew Form PRE 14A - AMARIN CORP PLC\UK <b>Filed:</b> 2026-03-30 <b>AccNo:</b> 0001193125-26-132114 <b>Size:</b> 5 MB
Read moreAmarin Highlights Guideline Recommended Role of Icosapent Ethyl in Managing Cardiovascular Risk Following Release of Updated 2026 ACC/AHA/Multisociety Dyslipidemia Guideline
Read moreNew REDUCE-IT Data in Patients at Extreme Cardiovascular Risk and In Vitro Research on the Mechanistic Effects of Eicosapentaenoic Acid (EPA) on Lipoprotein(a) [Lp(a)] Oxidation to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo
Read more